Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting Haz 18, 2024 System Admin Healthcare
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome Haz 17, 2024 System Admin Healthcare
Janzour waste collection and composting stations inaugurated – with help of the EU, German Embassy and GIZ Haz 15, 2024 Beatriz Escanilla Healthcare
Health minister enhances medical preparations for high temperatures during Eid Al-Adha Haz 15, 2024 Beatriz Escanilla Healthcare
Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI) Haz 14, 2024 System Admin Healthcare
جلسة عمل على هامش منتدى الاستثمار تبحث سبل تعزيز التعاون بين القطاعين العام والخاص في مجال الأدوية Haz 14, 2024 Btissam Gari Healthcare
Al-Khadra Hospital performs first ever lung and rib cage surgeries Haz 14, 2024 Beatriz Escanilla Healthcare
Qatar Chamber, MoPH discuss challenges facing private health sector Haz 14, 2024 Beatriz Escanilla Healthcare
